Hello! You are part of a community of millions who seek out Democracy Now! each month for ad-free daily news you can trust. Maybe you come for our daily headlines. Maybe you come for our in-depth stories that expose corporate and government abuses of power and lift up the voices of ordinary people working to make change in extraordinary times. We produce all of this news at a fraction of the budget of a commercial news operation. We do this without ads, government funding or corporate sponsorship. How? This model of news depends on support from viewers and listeners like you. Today, less than 1% of our visitors support Democracy Now! with a donation each year. If even 3% of our website visitors donated just $10 per month, we could cover our basic operating expenses for a year. Pretty amazing right? If you visit us daily or weekly or even just once a month, now is a great time to make a monthly contribution.

Your Donation: $

Tuesday, August 21, 2001

download:   Get CD/DVD More Formats
  • 13th Amendment Blocks Patents on Stem Cell and Cloning Technologies

    As research in the areas of stem cells and cloning continues to progress, various American and European biotechnology companies are racing to patent new techniques and technologies. However, they are running into barriers in the form of laws against the ownership of human beings. In the US, the 13th Amendment, which was drafted to abolish slavery and outlaws the ownership of people, makes the language of more ambiguous patents troublesome because of references to the cloning of "animals," including humans. Europe also has universal bans on the patenting of technology related to the cloning of humans, but the European patent office has made a number of errors allowing for such procedures to become privatized in the past.

  • Biotech Companies Continue to Push for Legislation Encouraging Genetically Modified Foods

    Biotech companies connected to the American agriculture industry are investing large sums of money into developing genetically modified foods for the US consumer market while lobbying the government to pass legislation that would reduce controls on the production of American-grown food and limit consumer choice. As concerns are raised about the dangers of genetically modified foods, the industry is attempting to pass legislation as quickly as possible to side step potential adverse studies.